Predicting Immunotherapy Efficacy with Machine Learning in Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.

Int J Mol Sci · 2025 · PMC12250185 · PMID 40649716

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

a strong trendp = 0.052so close (0.05 < p ≤ 0.1)

According to the plotter, M6PR-high patients show a strong trend towards increased survival [HR:0.64 (0.45–1.01), p = 0.052], when including patients from all stages; and a significantly increased survival in the case of advanced-stage (III–IV) GC patients [HR:0.63 (0.42–0.95), p = 0.026].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.